Gilead Sciences (GILD, $65.51) was a top loser over the last three months, falling -1 to $65.51 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry for the 3-month period ending May 1, 2024, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.